Cargando…

DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis

As an indispensable factor in DNA damage recognition step of nucleotide excision repair, XPA interacts with a series of proteins to initiate repair process. The expression characteristics of XPA in colorectal cancer (CRC) and its influence on CRC prognosis remain elusive. Tissue specimens of CRC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xue, Liu, Jingwei, Gong, Yuehua, Gou, Kaihua, Yang, Huaiwei, Yuan, Yuan, Xing, Chengzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010851/
https://www.ncbi.nlm.nih.gov/pubmed/29675892
http://dx.doi.org/10.1002/cam4.1480
_version_ 1783333675786567680
author Feng, Xue
Liu, Jingwei
Gong, Yuehua
Gou, Kaihua
Yang, Huaiwei
Yuan, Yuan
Xing, Chengzhong
author_facet Feng, Xue
Liu, Jingwei
Gong, Yuehua
Gou, Kaihua
Yang, Huaiwei
Yuan, Yuan
Xing, Chengzhong
author_sort Feng, Xue
collection PubMed
description As an indispensable factor in DNA damage recognition step of nucleotide excision repair, XPA interacts with a series of proteins to initiate repair process. The expression characteristics of XPA in colorectal cancer (CRC) and its influence on CRC prognosis remain elusive. Tissue specimens of CRC and nontumor adjacent tissues from 283 patients were collected. XPA protein expressions were detected by immunohistochemistry staining. Nonparametric test was used to investigate the difference of XPA expression between CRC and nontumor adjacent tissues, as well as the correlation between XPA expression and clinicopathological parameters of CRC. Univariate and multivariate Cox proportional hazards models were applied to estimate the relationship between XPA expression and CRC prognosis. Meanwhile, we analyzed TCGA data to investigate the relation between XPA mRNA expression and survival of CRC. XPA protein expression was significantly decreased in CRC tissues compared with nontumor adjacent tissues (P = 0.001). Subgroup analysis indicated consistently significant down‐regulation of XPA in CRC tissues in age > 60 (P = 0.026), age ≤ 60 (P = 0.008), colon cancer (P = 0.009), and rectal cancer (P = 0.015) patients and males (P = 0.004). For clinicopathological parameters, CRC patients with drinking habits revealed XPA overexpression than nondrinkers (P = 0.032). For prognosis, CRC patients with high XPA protein expression had longer overall survival (OS) (HR = 0.62, 95%CI: 0.39–0.97, P = 0.037). Stratified analysis suggested a better prognosis in relation to high XPA protein expression in patients over 60 years (adjusted HR = 0.48, P = 0.021), with rectal cancer (HR = 0.56, P = 0.037), without distant metastasis (HR = 0.58, P = 0.033), without tumor deposits (HR = 0.40, P = 0.006; adjusted HR = 0.44, P = 0.028), and with tumor diameter over 4 cm (HR = 0.49, P = 0.023). DNA repair protein XPA is significantly decreased in colorectal cancer tissues than in adjacent nontumor tissues. High expression of XPA protein showed significant relationship with better survival of CRC, especially rectal cancer. XPA might be a novel biomarker but might not be an independent factor to predict prognosis of CRC patients.
format Online
Article
Text
id pubmed-6010851
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60108512018-06-27 DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis Feng, Xue Liu, Jingwei Gong, Yuehua Gou, Kaihua Yang, Huaiwei Yuan, Yuan Xing, Chengzhong Cancer Med Clinical Cancer Research As an indispensable factor in DNA damage recognition step of nucleotide excision repair, XPA interacts with a series of proteins to initiate repair process. The expression characteristics of XPA in colorectal cancer (CRC) and its influence on CRC prognosis remain elusive. Tissue specimens of CRC and nontumor adjacent tissues from 283 patients were collected. XPA protein expressions were detected by immunohistochemistry staining. Nonparametric test was used to investigate the difference of XPA expression between CRC and nontumor adjacent tissues, as well as the correlation between XPA expression and clinicopathological parameters of CRC. Univariate and multivariate Cox proportional hazards models were applied to estimate the relationship between XPA expression and CRC prognosis. Meanwhile, we analyzed TCGA data to investigate the relation between XPA mRNA expression and survival of CRC. XPA protein expression was significantly decreased in CRC tissues compared with nontumor adjacent tissues (P = 0.001). Subgroup analysis indicated consistently significant down‐regulation of XPA in CRC tissues in age > 60 (P = 0.026), age ≤ 60 (P = 0.008), colon cancer (P = 0.009), and rectal cancer (P = 0.015) patients and males (P = 0.004). For clinicopathological parameters, CRC patients with drinking habits revealed XPA overexpression than nondrinkers (P = 0.032). For prognosis, CRC patients with high XPA protein expression had longer overall survival (OS) (HR = 0.62, 95%CI: 0.39–0.97, P = 0.037). Stratified analysis suggested a better prognosis in relation to high XPA protein expression in patients over 60 years (adjusted HR = 0.48, P = 0.021), with rectal cancer (HR = 0.56, P = 0.037), without distant metastasis (HR = 0.58, P = 0.033), without tumor deposits (HR = 0.40, P = 0.006; adjusted HR = 0.44, P = 0.028), and with tumor diameter over 4 cm (HR = 0.49, P = 0.023). DNA repair protein XPA is significantly decreased in colorectal cancer tissues than in adjacent nontumor tissues. High expression of XPA protein showed significant relationship with better survival of CRC, especially rectal cancer. XPA might be a novel biomarker but might not be an independent factor to predict prognosis of CRC patients. John Wiley and Sons Inc. 2018-04-19 /pmc/articles/PMC6010851/ /pubmed/29675892 http://dx.doi.org/10.1002/cam4.1480 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Feng, Xue
Liu, Jingwei
Gong, Yuehua
Gou, Kaihua
Yang, Huaiwei
Yuan, Yuan
Xing, Chengzhong
DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title_full DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title_fullStr DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title_full_unstemmed DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title_short DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis
title_sort dna repair protein xpa is differentially expressed in colorectal cancer and predicts better prognosis
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010851/
https://www.ncbi.nlm.nih.gov/pubmed/29675892
http://dx.doi.org/10.1002/cam4.1480
work_keys_str_mv AT fengxue dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT liujingwei dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT gongyuehua dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT goukaihua dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT yanghuaiwei dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT yuanyuan dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis
AT xingchengzhong dnarepairproteinxpaisdifferentiallyexpressedincolorectalcancerandpredictsbetterprognosis